Literature DB >> 19540093

Tigecycline-induced acute pancreatitis: case report and literature review.

Whitney Y Hung1, Laura Kogelman, Gretchen Volpe, Mark Iafrati, Lisa Davidson.   

Abstract

Tigecycline is a broad-spectrum antimicrobial agent structurally related to minocycline. Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about tigecycline-induced acute pancreatitis have recently been raised. We describe a 69-year-old female who received tigecycline for treatment of a complicated skin and skin-structure infection. Following 7 days of tigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis. According to the Naranjo adverse drug reaction probability scale, tigecycline was the probable cause of her acute pancreatitis. Clinicians should be aware of this potential adverse effect of tigecycline. We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including abdominal pain, during treatment with tigecycline.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540093     DOI: 10.1016/j.ijantimicag.2009.05.004

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

Review 1.  Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Authors:  Yun Cai; Rui Wang; Beibei Liang; Nan Bai; Youning Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

2.  Multi-drug-resistant Klebsiella pneumoniae pancreatitis: a new challenge in a serious surgical infection.

Authors:  Derin Tugal; Melanie Lynch; Andrea M Hujer; Susan Rudin; Federico Perez; Robert A Bonomo
Journal:  Surg Infect (Larchmt)       Date:  2014-05-21       Impact factor: 2.150

3.  Acute necrotizing pancreatitis: can tigecycline be included in a therapeutic strategy?

Authors:  S Occhionorelli; L Morganti; R Cultrera; D Andreotti; S Maccatrozzo; L Cappellari; R Stano; G Vasquez
Journal:  G Chir       Date:  2015 Jan-Feb

4.  Late onset acute pancreatitis in P. falciparum malaria - An adverse reaction to intravenous artesunate?

Authors:  Asmaa S Mahdi; Mariya Molai; Juhi Chandwani; Huda Al Khalili; Hashim Ibrahim; Nenad Pandak; Faryal Khamis; Eskild Petersen
Journal:  IDCases       Date:  2018-04-30

Review 5.  Contemporary review of drug-induced pancreatitis: A different perspective.

Authors:  Whitney Y Hung; Odaliz Abreu Lanfranco
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

6.  Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.

Authors:  Mary L Townsend; Melanie W Pound; Richard H Drew
Journal:  Infect Drug Resist       Date:  2011-03-02       Impact factor: 4.003

7.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Alicia I Hidron; Russell Kempker; Abeer Moanna; David Rimland
Journal:  Infect Drug Resist       Date:  2010-08-06       Impact factor: 4.003

Review 8.  Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.

Authors:  Christian Eckmann; M Dryden
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

9.  Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.

Authors:  Paul D Santos; Amanda Davis; Alena Jandourek; Alexander Smith; H David Friedland
Journal:  J Chemother       Date:  2013-12-06       Impact factor: 1.714

10.  Pancreatitis in tigecycline Phase 3 and 4 clinical studies.

Authors:  Paul C McGovern; Michele Wible; Joan M Korth-Bradley; Alvaro Quintana
Journal:  J Antimicrob Chemother       Date:  2013-11-11       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.